Shandong Aonai Biopharmaceutical Co., Ltd., a professional pet supplement manufacturer and pet supplement supplier based in Linyi City, Shandong Province, China, has officially become a member unit of the Pet Industry Working Committee of the China Entry-Exit Inspection and Quarantine Association (CIQA). The membership certificate, number C08372602196M, is valid from June 10, 2026 to June 10, 2027. This recognition by a national-level industry organization marks an important step in the company's compliance building and its integration into the broader Chinese pet industry ecosystem.
The China Entry-Exit Inspection and Quarantine Association is a national, industry-wide social organization approved by the Ministry of Civil Affairs. It is dedicated to promoting the development of China's entry-exit inspection and quarantine services and to supporting foreign trade and quality safety. The association brings together inspection and quarantine authorities, industry associations, research institutions, and import/export enterprises, serving as an important bridge for policy communication, standards building, technical exchange, and international cooperation.
Its Pet Industry Working Committee is one of the most influential industry organizations in China's pet sector, focusing on pet industry development and import/export trade. Its main functions include:
Participating in the formulation and revision of pet industry standards and specifications to promote industry standardization;
Building a government‒enterprise communication bridge to help companies accurately grasp the latest policies on import/export inspection and quarantine;
Organizing industry exchanges, technical seminars, and market development activities to promote collaboration across the industry chain;
Connecting international market resources to help Chinese pet companies "go global" and enhance their international competitiveness.
1. Enhanced industry credibility. Joining the Pet Industry Working Committee of CIQA is authoritative recognition of Shandong Aonai Biopharmaceutical's R&D strength, production capability, and compliance level in the pet nutrition field. The endorsement of a national-level industry organization further strengthens the trust of domestic and international customers in the company's brand and products.
2. Stronger policy and compliance capabilities. Through the association's platform, the company will gain first-hand, timely access to the latest developments in import/export inspection and quarantine, pet food regulations, and international trade policies, allowing it to continuously refine its product compliance systems, ensure compliant sales in domestic and international markets, and effectively mitigate trade risks.
3. Deep collaboration across the industry chain. Leveraging the association's rich industry resources, the company can strengthen exchanges and cooperation with upstream and downstream enterprises, research institutions, testing organizations, and regulatory authorities in the pet food industry chain ― creating more opportunities in cutting-edge technology, raw material supply, and channel expansion.
4. Accelerated international market development. The association's deep experience in international trade promotion will help the company better connect with overseas market demand, accelerate the global layout of its Dr.kalan product line, and enhance the international influence of Chinese pet nutrition brands.
Shandong Aonai Biopharmaceutical has always regarded product quality and compliant operations as the lifeline of its business. The company has built a full-chain quality management system covering raw material selection, R&D and production, and finished product inspection. Its R&D professional has obtained the U.S. FSPCA PCQI certification for animal food preventive controls; its core technologies ― the Dr.kalan compound probiotic and the gastric acid-resistant Dr.kalan collagen peptide ― have been filed as international invention patent applications, creating proprietary technology barriers for the company.
As a new member of the Pet Industry Working Committee, the company commits to: strictly abide by the association's charter, actively fulfill its membership obligations, proactively participate in industry standard building and quality safety co-governance, and work hand in hand with industry peers to promote the high-quality and sustainable development of China's pet industry.
For international brands and distributors evaluating suppliers, this membership adds another layer of assurance to the company's profile as a pet supplement manufacturer and pet supplement supplier. Combined with its OEM/ODM, private label, bulk supply, and custom formula service capabilities, the company offers partners a rare combination of technical depth, regulatory compliance, and manufacturing reliability in the pet nutrition industry.
Shandong Aonai Biopharmaceutical Co., Ltd. is a science-driven pet health enterprise located in the Wenshui Industrial Park, Pingyi County, Linyi City, Shandong Province, China. The company integrates R&D, production, and sales, with a product portfolio spanning dog joint supplements, dog multivitamins, dental care products, and digestive & probiotic supplements under its Dr.kalan brand. As an experienced pet supplement manufacturer and pet supplement supplier, the company offers flexible OEM/ODM, private label, and custom formula services to brands and distributors worldwide. Its quality assurance system is backed by an FSPCA PCQI-certified R&D team, and the company holds multiple international invention patent applications covering its Dr.kalan compound probiotics and gastric acid-resistant collagen peptides. Committed to "quality first, safety first, technology driven," Shandong Aonai is dedicated to delivering safe, scientific, and premium pet health products to pets and pet parents around the world.
Looking to the future, Shandong Aonai Biopharmaceutical will take this membership as a new starting point, rooted in China and reaching out to the world, continuing to increase its investment in R&D and compliance to contribute greater strength to the high-quality development of China's pet industry.
EN
